Clinical Trials Directory

Trials / Terminated

TerminatedNCT01770340

Nerve Grafting With an Allograft During Radical Prostatectomy - Extended Follow-up in a Prospective Randomized Trial

Status
Terminated
Phase
Phase 4
Study type
Interventional
Enrollment
30 (actual)
Sponsor
Kantonsspital Winterthur KSW · Academic / Other
Sex
Male
Age
18 Years
Healthy volunteers
Not accepted

Summary

Earlier studies were able to show that an improvement of the erectile function following a non-nerve sparing radical prostatectomy could be achieved using an autologous nerve graft. The investigators evaluate the use of the implantation of the allogenic nerve graft Avance® in patients undergoing non nerve-sparing radical prostatectomy.

Detailed description

In this prospective randomised and single-blind, clinical phase-IV study, 60 patients are randomized into the treatment group and the control group. The follow-up is at least 24 months. The inclusion criteria were localized prostate cancers cT3 and/or Gleason score ≥ 7 (a or b) and/or prostate-specific antigen (PSA) ≥ 20 ng/ml and furthermore an erectile function with an IIEF ≥ 21 (IIEF-6). The operation carried out is a standardised, robot assisted laparoscopic radical prostatectomy with total excision of both neurovascular bundles. The Outcome measurement is done with the "quality of life questionnaire before and after prostate surgery" that includes the "International Index of Erectile Function" (IIEF) questionnaire. The limitations are a small cohort, a short observation period and the lack of statistical analysis due to a still low number of patients.

Conditions

Interventions

TypeNameDescription
BIOLOGICALRadical prostatectomy with implantation of allograftInterposition of resected neurovascular bundles with allograft Avance®
PROCEDURERadical prostatectomy without implantation of allograftNo interposition of resected neurvascular bundles

Timeline

Start date
2011-01-01
Primary completion
2017-04-01
Completion
2020-07-01
First posted
2013-01-17
Last updated
2021-02-21

Locations

1 site across 1 country: Switzerland

Source: ClinicalTrials.gov record NCT01770340. Inclusion in this directory is not an endorsement.